ENTITY
Immunotech Biopharm

Immunotech Biopharm (6978 HK)

16
Analysis
Health Care • China
Immunotech Biopharm is a cellular immunotherapy biopharmaceutical company in China, focused on the research, development, and commercialization of T-cell immunotherapy for cancer treatments. Its key products include EAL (Expanded Activated Lymphocytes), CAR-T cell series, and TCR-T cell series products. The company is headquartered in Beijing, China, and was founded in 2006.
more
Exchange Announcement • 30 Sep 2026 18:30

Supplemental Announcement To The Annual Report For The Year Ended 31 December 2025

Exchange Announcement • 18 Sep 2026 17:58

2026 Interim Report

Exchange Announcement • 21 Aug 2026 22:29

Announcement Of The Interim Results For The Six Months Ended 30 June 2026

Exchange Announcement • 11 Aug 2026 20:44

Date Of Board Meeting

Exchange Announcement • 03 Jun 2026 22:52

Voluntary Announcement Update On Status Of Eal And Approval For Clinical Translational Application Of Atl

x